pSivida sells subsidiary for $3.6m

PERTH-HEADQUARTERED bio-nanotech company, pSivida Ltd, has sold its subsidiary AION Diagnostics Inc to US-based private equity group GEM Global Yield Fund for around $3.6 million, following the company’s planned float on the Frankfurt Stock Exchange. pSivida said GEM had agreed to pay $US3 million, payable in two equal installments upon the completion of an initial public offering of AION’s stock on the Frankfurt Stock Exchange and $US1.5 million, payable no later than 12 months after the closing of the transaction, in exchange for pSivida’s entire holdings in AION. pSivida has provided an exclusive license for the non-electronic imaging diagnostic applications of BioSiliconTM technology to AION Diagnostics. pSivida will receive royalties from all commercialised products.

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
10th-The University of Notre Dame Australia6,708
47 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer